<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26300438</article-id>
      <article-id pub-id-type="pmc">4751134</article-id>
      <article-id pub-id-type="publisher-id">14-0643</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.14-0643</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Internal Medicine</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Elevation of serum surfactant protein-A with exacerbation in canine
eosinophilic pneumonia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>SONE</surname>
            <given-names>Katsuhito</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>AKIYOSHI</surname>
            <given-names>Hideo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HAYASHI</surname>
            <given-names>Akiyoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>OHASHI</surname>
            <given-names>Fumihito</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Department of Veterinary Clinical Sciences, Graduate School
of Life and Environmental Sciences, Osaka Prefecture University, 1&#x2013;58 Rinku-ohrai-kita,
Izumisano, Osaka 598&#x2013;8531, Japan</aff>
        <aff id="aff2"><label>2)</label>Okayama Animal Medical Center Hospital, 456&#x2013;1 Nishiichi,
Minami-ku, Okayama, Okayama 700&#x2013;0953, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Akiyoshi, H., Department of Veterinary
Clinical Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture
University, 1&#x2013;58 Rinku Ohrai Kita, Izumisano, Osaka 598&#x2013;8531, Japan. e-mail: <email xlink:href="akiyoshi@vet.osakafu-u.ac.jp">akiyoshi@vet.osakafu-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <volume>78</volume>
      <issue>1</issue>
      <fpage>143</fpage>
      <lpage>146</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 7-year-old female spayed Labrador Retriever was admitted to our hospital, because of
cough with sputum. She was diagnosed as having canine eosinophilic pneumonia (CEP) based
on blood eosinophilia, bronchial pattern and infiltrative shadow observed on thoracic
radiography, bronchiolar obstruction and air-space consolidation predominantly affecting
the right caudal lung lobe, as revealed by computed tomography (CT), predominant
eosinophils in CT-guided fine needle aspiration and the clinical course. She exhibited a
good response to steroid therapy, and the cough disappeared. The serum surfactant protein
(SP)-A level increased with the aggravated symptom and decreased markedly with improvement
compared with the C-reactive protein level and the number of eosinophils. We propose that
serum SP-A level is a good biomarker in CEP.</p>
      </abstract>
      <kwd-group>
        <kwd>canine</kwd>
        <kwd>eosinophilic pneumonia</kwd>
        <kwd>surfactant protein-A</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Canine eosinophilic pneumonia (CEP) is an interstitial lung disease that is characterized by
eosinophilic infiltration of the terminal bronchioles, alveoli and blood vessels [<xref rid="r6" ref-type="bibr">6</xref>]. Peripheral blood eosinophilia is found in 50&#x2013;70% of all
cases, and time-dependent changes in the number of eosinophils may not correlate with disease
activity [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r16" ref-type="bibr">16</xref>].</p>
    <p>Pulmonary surfactant protein (SP)-A is a glycoprotein that plays an important role in natural
immunity of the lungs [<xref rid="r13" ref-type="bibr">13</xref>]. It is a component of
pulmonary surfactant, which is primarily synthesized and secreted by alveolar type II cells
[<xref rid="r23" ref-type="bibr">23</xref>]. In human medicine, the blood SP-A primarily
increases in interstitial lung disease and is indicated as a pulmonary-specific biomarker
[<xref rid="r21" ref-type="bibr">21</xref>]. Time-dependent changes in serum SP-A levels
have been studied as a potentially useful way to monitor the state of eosinophilic pneumonia,
a type of interstitial pneumonia, in humans [<xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref>].</p>
    <p>In veterinary medicine, the blood SP-A level increases in pneumonopathies, such as canine
aspiration pneumonia, primary lung tumor, blunt traumatic lung injury, diffuse panbronchitis
and idiopathic pulmonary fibrosis, and measurement of SP-A has recently been useful in
differentiating these from other diseases [<xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. However, there have been no reports in which the blood
SP-A has been monitored over the course of the disease and the relationship between the SP-A
level and disease activity. Herein, we present a case of canine eosinophilic pneumonia, in
which serum SP-A levels fluctuated with the disease condition. We propose that measuring serum
SP-A is helpful for monitoring disease activity.</p>
    <p>A 7-year-old female spayed Labrador Retriever, weighing 23.5 kg, was admitted to Okayama
Animal Medical Center Hospital because of cough with clear sputum for the past week (Day 0),
which continued for approximately 20 min once over 2 days. There was no medical history, and
the dog had regularly received the prophylactic vaccine and heartworm prophylaxis. Physical
examination on admission revealed a heart rate of 114 beats/min, respiratory rate of 36
breaths/min, temperature of 38.4&#xB0;C and normal lung auscultation. Complete blood count showed
hypereosinophilia of 2,524/<italic>&#xB5;l </italic>(range, 100&#x2013;750/<italic>&#xB5;l</italic>). Blood
microfilaria was negative. The plasma C-reactive protein (CRP) level (Laser CRP-2; ARROW
MEDICAL Co., Ltd., Yokohama, Japan) was normal at 0 mg/d<italic>l </italic>(range, &lt;1.0
mg/d<italic>l</italic>). Blood chemical examinations were within the reference range.
Thoracic radiographs revealed a mild bronchial pattern throughout the lungs. The antigen test
for heartworm disease and fecal examination were not conducted.</p>
    <p>Based on these findings, we suspected chronic bronchial disease [<xref rid="r11" ref-type="bibr">11</xref>] and started treatment with aminophylline [4.3 mg/kg, per os (PO), bis
in die (BID)] and tranexamic acid (10.6 mg/kg, PO, BID) without any steroid.</p>
    <p>On Day 5, the dog revisited our hospital, because her cough had worsened and the sputum had
turned from clear to yellow. Therefore, we added the antibiotic enrofloxacin [5.2 mg/kg, PO,
semel in die (SID)] and switched from tranexamic acid to carprofen (2.1 mg/kg, PO, SID).</p>
    <p>On Day 12, the dog was re-admitted, because her symptom worsened, and the sputum included
blood. We hospitalized her in an oxygen cage, because she was mildly cyanotic. The blood
oxygenation, i.e., blood gas analysis, was not measured. The number of eosinophils decreased
to 1,932/<italic>&#xB5;l</italic>, and the CRP level increased slightly to 2.0
mg/d<italic>l</italic>. On thoracic radiographs, the bronchial pattern was more severe than
those obtained previously, and there was an infiltrative shadow in the right caudal lung lobe
(<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>A ventral-dorsal radiograph of the dog&#x2019;s thorax on Day 12. The radiograph shows a
bronchial pattern throughout the lungs and an infiltrative shadow in the right caudal
lung lobe (arrow).</p></caption><graphic xlink:href="jvms-78-143-g001"/></fig>).</p>
    <p>Computed tomography (CT) (Pro Speed FII, GE Healthcare, Hino, Japan) performed on Day 13
identified thickened bronchial walls, and local and peripheral bronchiolar obstructions, which
suggested bronchial disease with the accumulation of secretions in the peripheral bronchi. CT
also identified infiltrative shadows with ground-glass opacity in the right caudal lung lobe
just below the pleura (considered the main lesion) (<xref ref-type="fig" rid="fig_002">Fig.
2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Transverse CT thorax image at the level of the ninth thoracic vertebra on Day 13. The
image shows thickened bronchial walls, local and peripheral bronchiolar obstructions
(circle with the dotted line) and infiltrative shadows just below the pleura
(arrow).</p></caption><graphic xlink:href="jvms-78-143-g002"/></fig>), which suggested lung interstitial and parenchymal disease, including pneumonia,
abscesses or bleeding. Therefore, we performed CT-guided fine needle aspiration (FNA) using a
24-gauge needle for the differential diagnosis on the main lesion and observed inflammatory
cells, comprised mainly of eosinophils and alveolar cells (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Cytology from the CT-guided fine needle aspirate of the dog&#x2019;s main lung lesion on Day
13. Inflammatory cells, composed mainly of eosinophils (arrow), were observed. Giemsa
stain, &#xD7; 400.</p></caption><graphic xlink:href="jvms-78-143-g003"/></fig>). Cytodiagnosis was made by the veterinary pathology specialists at Sumitomo Chemistry
Techno Service Co., Ltd. Osaka, Japan. The possibility of overestimating eosinophils in FNA by
aspirating the peripheral blood with hypereosinophilia, compared with the ratio of red blood
cell to eosinophil counts on the smear preparation of the lung specimen with the ratio of that
in the peripheral blood was unlikely. Eosinophilic pneumonia was suspected on the basis of
blood eosinophilia and the results of thoracic radiography, CT and CT-guided FNA.</p>
    <p>Thus, we administered prednisolone (1 mg/kg, subcutaneously), and her symptoms improved
considerably on Day 14. We then prescribed prednisolone (0.42 mg/kg, PO, SID) and discharged
her. We continued enrofloxacin as an antimicrobial in case a bacterial infection had been
missed.</p>
    <p>The subsequent disease course was favorable, and the symptom was relieved on Day 19.
Thereafter, we progressively reduced the prednisolone dose. Enrofloxacin was discontinued on
Day 26; prednisolone was discontinued on Day 54, because there was no symptom recurrence.
However, cough recurred 1 week later (Day 61), and prednisolone therapy was re-initiated (0.21
mg/kg, PO, SID). Prednisolone was continued, and treatment was finally completed 16 months
after the initial visit. The dog is currently healthy with no recurrence 43 months later.</p>
    <p>We measured serum SP-A levels during the treatment period with the consent of the pet owner
(<xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Blood eosinophil counts (Eos: white triangle), serum SP-A levels (black square) and
plasma C-reactive protein level (CRP: white circle) during the dog&#x2019;s clinical course.
Po, per os; Sid, semel in die; Qod, quaque one die; Sc, subcutaneous.</p></caption><graphic xlink:href="jvms-78-143-g004"/></fig>). Serum samples were retrieved from blood samples that were not used for medical
examinations and were stored at &#x2212;80&#xB0;C. The frozen samples were transported to Osaka Prefecture
University, wherein the individual measurements were performed. The serum SP-A levels were
measured by sandwich enzyme-linked immunosorbent assay using rabbit anti-dog SP-A polyclonal
antibody, as previously reported [<xref rid="r19" ref-type="bibr">19</xref>]. The serum SP-A
level was 4.5 <italic>n</italic>g/m<italic>l</italic> (median concentration in healthy dogs,
&lt;2.0 <italic>n</italic>g/m<italic>l</italic>) [<xref rid="r20" ref-type="bibr">20</xref>]
at the initial visit, but increased considerably to 35.5
<italic>n</italic>g/m<italic>l</italic> when the symptom became aggravated on Day 12. This
level subsequently decreased as the symptom improved after starting steroid therapy, and was
1.4 <italic>n</italic>g/m<italic>l</italic>, the minimum value, on Day 26. However, its level
increased slightly again to 6.9 <italic>n</italic>g/m<italic>l</italic> on Day 61, one week
after withdrawal of the steroid, as we tapered the prednisolone dose.</p>
    <p>The serum SP-A level was extremely high on the day when the symptom worsened considerably,
and it changed with the degree of clinical manifestations and thoracic radiographs findings.
The elevation of serum SP-A during the exacerbation could not be explained, because the
pathological processes involved in canine eosinophilic pneumonia has only previously been
investigated using bronchoalveolar lavage (BAL) cytology and histological examination of the
bronchial mucosa; however, information regarding the lung parenchyma remains lacking [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r14" ref-type="bibr">14</xref>]. In human
chronic eosinophilic pneumonia, resembling CEP [<xref rid="r15" ref-type="bibr">15</xref>],
infiltration of eosinophils and lymphocytes occurs into the alveoli and at the alveolar
epithelium with destruction of the basal membrane [<xref rid="r12" ref-type="bibr">12</xref>].
Eosinophils release granule proteins, oxygen radicals, lipid mediators and cytokines, which
increase vascular permeability and/or cause leukocyte accumulation [<xref rid="r18" ref-type="bibr">18</xref>]. From the results showing that the BAL fluid and serum SP-A levels are
both increased in human acute eosinophilic pneumonia, Daimon <italic>et al</italic>. reported
the possibility that serum SP-A levels could be elevated due to hyperplasia of alveolar type
II cells and by the increase in permeability of the alveoli into the circulation due to the
destruction of the alveolar epithelium and endothelial cells [<xref rid="r8" ref-type="bibr">8</xref>].</p>
    <p>Glucocorticoids are the mainstay drug for the management of CEP [<xref rid="r5" ref-type="bibr">5</xref>]. Steroids interfere with the transcription of several proinflammatory
genes, i.e., interleukin (IL)-3, IL-4, IL-5, GM-CSF and various chemokines, which are
necessary for eosinophil maturation, proliferation, chemoattraction, adhesion and migration,
activation, and longevity [<xref rid="r17" ref-type="bibr">17</xref>]. Therefore, we
speculated that lung injury by eosinophils improved with the steroids and the leakage of SP-A
from the alveoli into the circulation decreased.</p>
    <p>CRP is an acute phase protein that is primarily produced in the liver and is stimulated by
inflammatory cytokines, primarily IL-6, which is mainly secreted by macrophages [<xref rid="r1" ref-type="bibr">1</xref>]. The CRP level is a useful marker of acute inflammation
in both humans and dogs. In humans, it is routinely used as an index of inflammation in
evaluating the effect of treatment, monitoring the progression of disease, and in determining
the prognosis, but it is not pulmonary-specific [<xref rid="r3" ref-type="bibr">3</xref>]. In
this case, the plasma CRP level increased slightly only on the day on which the acute symptom
exacerbation occurred (Day 12); except for Day 12, the CRP level was within the reference
range. Viitane <italic>et al</italic>. reported that dogs with eosinophilic pneumonia (EP)
exhibited significantly lower CRP levels than dogs with bacterial pneumonia and that the CRP
levels were similar between dogs with EP and healthy controls at the initial presentation,
which is consistent with our findings [<xref rid="r22" ref-type="bibr">22</xref>]. Chihara
<italic>et al</italic>. reported that serum CRP levels were lower in patients with
eosinophilic pneumonia compared with patients with bacterial pneumonia because they may
exhibit decreased IL-6 production or decreased liver reactivity for IL-6 [<xref rid="r4" ref-type="bibr">4</xref>]. No marked differences have been found in the expression
of IL-6 mRNA in bronchial biopsies from control dogs and dogs with EP [<xref rid="r15" ref-type="bibr">15</xref>]. It was speculated that the expression of IL-6 did not increase;
consequently, the CRP level did not increase in dogs with EP according to these results.</p>
    <p>In this study, the number of eosinophils was the highest on the day of admission, but
decreased on the day when the symptom worsened (Day 12). Thus, time-dependent changes in the
number of eosinophils did not correlate with disease activity, which is consistent with a
previous report [<xref rid="r16" ref-type="bibr">16</xref>]. The serum SP-A levels more
precisely reflected the disease condition in this case. We propose that measuring the serum
SP-A is useful for monitoring disease activity and clarifying the pathological condition of
canine eosinophilic pneumonia.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Agassandian</surname><given-names>M.</given-names></name><name><surname>Shurin</surname><given-names>G. V.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Shurin</surname><given-names>M. R.</given-names></name></person-group><year>2014</year>. <article-title>C-reactive protein and lung
diseases</article-title>. <source><italic>Int. J. Biochem. Cell
Biol.</italic></source><volume>53</volume>: <fpage>77</fpage>&#x2013;<lpage>88</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/j.biocel.2014.05.016</pub-id><pub-id pub-id-type="pmid">24853773</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Caswell</surname><given-names>J. L.</given-names></name><name><surname>Williams</surname><given-names>K. J.</given-names></name></person-group><year>2007</year> Lungs. pp. 540&#x2013;575. <italic>In</italic>: Pathology of
Domestic Animals, 5th ed. (Maxie, M. G. ed.), Elsevier, Philadelphia.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Chalmers</surname><given-names>J. D.</given-names></name><name><surname>Singanayagam</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>A. T.</given-names></name></person-group><year>2008</year>. <article-title>C-reactive protein is an independent
predictor of severity in community-acquired pneumonia</article-title>.
<source><italic>Am. J. Med.</italic></source><volume>121</volume>:
<fpage>219</fpage>&#x2013;<lpage>225</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjmed.2007.10.033</pub-id><pub-id pub-id-type="pmid">18328306</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Chihara</surname><given-names>J.</given-names></name><name><surname>Urayama</surname><given-names>O.</given-names></name><name><surname>Yasuba</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Kurachi</surname><given-names>D.</given-names></name><name><surname>Nakajima</surname><given-names>S.</given-names></name></person-group><year>1995</year>. <article-title>Possible low response of C-reactive
protein production in eosinophilic pneumonia</article-title>. <source><italic>J. Clin.
Lab. Immunol.</italic></source><volume>47</volume>:
<fpage>33</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="pmid">8735434</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Clercx</surname><given-names>C.</given-names></name><name><surname>Peeters</surname><given-names>D.</given-names></name><name><surname>Snaps</surname><given-names>F.</given-names></name><name><surname>Hansen</surname><given-names>P.</given-names></name><name><surname>McEntee</surname><given-names>K.</given-names></name><name><surname>Detilleux</surname><given-names>J.</given-names></name><name><surname>Henroteaux</surname><given-names>M.</given-names></name><name><surname>Day</surname><given-names>M. J.</given-names></name></person-group><year>2000</year>. <article-title>Eosinophilic bronchopneumopathy in
dogs</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>14</volume>: <fpage>282</fpage>&#x2013;<lpage>291</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.2000.tb01168.x</pub-id><pub-id pub-id-type="pmid">10830542</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Cohn</surname><given-names>L. A.</given-names></name></person-group><year>2010</year> Pulmonary Parenchymal Disease. pp. 1096&#x2013;1119.
<italic>In</italic>: Textbook of Veterinary Internal Medicine, 7th ed. (Ettinger, S. J.
and Feldman, E. C. eds.), Elsevier, St. Louis.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Corcoran</surname><given-names>B.</given-names></name><name><surname>Thoday</surname><given-names>K.</given-names></name><name><surname>HenFrey</surname><given-names>J.</given-names></name><name><surname>Simpson</surname><given-names>J.</given-names></name><name><surname>Burnie</surname><given-names>A.</given-names></name><name><surname>Mooney</surname><given-names>C.</given-names></name></person-group><year>1991</year>
<article-title>Pulmonary infiltration with eosinophils
in 14 dogs</article-title>. <source><italic>J. Small Anim.
Pract.</italic></source><volume>32</volume>: <fpage>494</fpage>&#x2013;<lpage>502</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1748-5827.1991.tb00863.x</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Daimon</surname><given-names>T.</given-names></name><name><surname>Tajima</surname><given-names>S.</given-names></name><name><surname>Oshikawa</surname><given-names>K.</given-names></name><name><surname>Bando</surname><given-names>M.</given-names></name><name><surname>Ohno</surname><given-names>S.</given-names></name><name><surname>Sugiyama</surname><given-names>Y.</given-names></name></person-group><year>2005</year>. <article-title>KL-6 and surfactant proteins A and D in
serum and bronchoalveolar lavage fluid in patients with acute eosinophilic
pneumonia</article-title>. <source><italic>Intern.
Med.</italic></source><volume>44</volume>: <fpage>811</fpage>&#x2013;<lpage>817</lpage>. doi:
<pub-id pub-id-type="doi">10.2169/internalmedicine.44.811</pub-id><pub-id pub-id-type="pmid">16157978</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Kameda</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>K.</given-names></name><name><surname>Chiba</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Abe</surname><given-names>S.</given-names></name></person-group><year>2004</year>. <article-title>Elevated serum surfactant protein A and D
in a case of acute eosinophilic pneumonia</article-title>. <source><italic>Intern.
Med.</italic></source><volume>43</volume>: <fpage>423</fpage>&#x2013;<lpage>426</lpage>. doi:
<pub-id pub-id-type="doi">10.2169/internalmedicine.43.423</pub-id><pub-id pub-id-type="pmid">15206558</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Ideura</surname><given-names>G.</given-names></name><name><surname>Minamisawa</surname><given-names>A.</given-names></name><name><surname>Urushihata</surname><given-names>K.</given-names></name><name><surname>Hanaoka</surname><given-names>M.</given-names></name><name><surname>Miyahara</surname><given-names>T.</given-names></name><name><surname>Koizumi</surname><given-names>T.</given-names></name><name><surname>Fujimoto</surname><given-names>K.</given-names></name><name><surname>Kubo</surname><given-names>K.</given-names></name><name><surname>Tsukadaira</surname><given-names>A.</given-names></name></person-group><year>2004</year>. <article-title>A case of acute eosinophilic pneumonia
with a disassociation between the KL-6 level and SP-A and SP-D levels in the serum and
BAL fluid</article-title>. <source><italic>Nihon Kokyuki Gakkai
Zasshi</italic></source><volume>42</volume>:
<fpage>640</fpage>&#x2013;<lpage>644</lpage><comment>(in Japanese)</comment>. <pub-id pub-id-type="pmid">15357266</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Johnson</surname><given-names>L. R.</given-names></name></person-group><year>2014</year> Chronic Bronchial Disorders in Dogs. pp. 669&#x2013;672.
<italic>In</italic>: Kirk&#x2019;s Current Veterinary Therapy, 15th ed. (Bonagura, J. D. and
Twedt, D. C. eds.), Elsevier, St. Louis.</mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Mochimaru</surname><given-names>H.</given-names></name><name><surname>Kawamoto</surname><given-names>M.</given-names></name><name><surname>Fukuda</surname><given-names>Y.</given-names></name><name><surname>Kudoh</surname><given-names>S.</given-names></name></person-group><year>2005</year>. <article-title>Clinicopathological differences between
acute and chronic eosinophilic pneumonia</article-title>.
<source><italic>Respirology</italic></source><volume>10</volume>:
<fpage>76</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1440-1843.2005.00648.x</pub-id><pub-id pub-id-type="pmid">15691242</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Nayak</surname><given-names>A.</given-names></name><name><surname>Dodagatta-Marri</surname><given-names>E.</given-names></name><name><surname>Tsolaki</surname><given-names>A. G.</given-names></name><name><surname>Kishore</surname><given-names>U.</given-names></name></person-group><year>2012</year>. <article-title>An Insight into the Diverse Roles of
Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity</article-title>.
<source><italic>Front. Immunol.</italic></source><volume>3</volume>:
<fpage>131</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2012.00131</pub-id><pub-id pub-id-type="pmid">22701116</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Norris</surname><given-names>C. R.</given-names></name><name><surname>Mellema</surname><given-names>M. S.</given-names></name></person-group><year>2004</year> Eosinophilic Pneumonia. pp. 541&#x2013;547.
<italic>In</italic>: Textbook of Respiratory Disease in Dogs and Cats (King, L. G. ed.),
Elsevier, St. Louis.</mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Peeters</surname><given-names>D.</given-names></name><name><surname>Peters</surname><given-names>I. R.</given-names></name><name><surname>Clercx</surname><given-names>C.</given-names></name><name><surname>Day</surname><given-names>M. J.</given-names></name></person-group><year>2006</year>. <article-title>Real-time RT-PCR quantification of mRNA
encoding cytokines, CC chemokines and CCR3 in bronchial biopsies from dogs with
eosinophilic bronchopneumopathy</article-title>. <source><italic>Vet. Immunol.
Immunopathol.</italic></source><volume>110</volume>:
<fpage>65</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetimm.2005.09.004</pub-id><pub-id pub-id-type="pmid">16226318</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rajam&#xE4;ki</surname><given-names>M. M.</given-names></name><name><surname>Jarvinen</surname><given-names>A. K.</given-names></name><name><surname>Sorsa</surname><given-names>T.</given-names></name><name><surname>Maisi</surname><given-names>P.</given-names></name></person-group><year>2002</year>. <article-title>Clinical findings, bronchoalveolar lavage
fluid cytology and matrix metalloproteinase-2 and -9 in canine pulmonary
eosinophilia</article-title>. <source><italic>Vet.
J.</italic></source><volume>163</volume>: <fpage>168</fpage>&#x2013;<lpage>181</lpage>. doi:
<pub-id pub-id-type="doi">10.1053/tvjl.2001.0631</pub-id><pub-id pub-id-type="pmid">12093192</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rothenberg</surname><given-names>M. E.</given-names></name></person-group><year>1998</year>. <article-title>Eosinophilia</article-title>.
<source><italic>N. Engl. J. Med.</italic></source><volume>338</volume>:
<fpage>1592</fpage>&#x2013;<lpage>1600</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJM199805283382206</pub-id><pub-id pub-id-type="pmid">9603798</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Simon</surname><given-names>D.</given-names></name><name><surname>Wardlaw</surname><given-names>A.</given-names></name><name><surname>Rothenberg</surname><given-names>M. E.</given-names></name></person-group><year>2010</year>. <article-title>Organ-specific eosinophilic disorders of
the skin, lung, and gastrointestinal tract</article-title>. <source><italic>J. Allergy
Clin. Immunol.</italic></source><volume>126</volume>:
<fpage>3</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2010.01.055</pub-id><pub-id pub-id-type="pmid">20392477</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sone</surname><given-names>K.</given-names></name><name><surname>Akiyoshi</surname><given-names>H.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Sugii</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>F.</given-names></name></person-group><year>2011</year>. <article-title>Development and validation of a sandwich
ELISA for use in measuring concentrations of canine surfactant protein A in serum of
dogs</article-title>. <source><italic>Am. J. Vet.
Res.</italic></source><volume>72</volume>: <fpage>833</fpage>&#x2013;<lpage>837</lpage>. doi:
<pub-id pub-id-type="doi">10.2460/ajvr.72.6.833</pub-id><pub-id pub-id-type="pmid">21627531</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sone</surname><given-names>K.</given-names></name><name><surname>Akiyoshi</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>A.</given-names></name><name><surname>Sugii</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>F.</given-names></name></person-group><year>2013</year>. <article-title>Surfactant protein-A concentration in
sera from dogs with pulmonary parenchymal diseases</article-title>. <source><italic>J.
Vet. Med. Sci.</italic></source><volume>75</volume>:
<fpage>685</fpage>&#x2013;<lpage>691</lpage>. doi: <pub-id pub-id-type="doi">10.1292/jvms.12-0255</pub-id><pub-id pub-id-type="pmid">23328605</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Shiratori</surname><given-names>M.</given-names></name><name><surname>Kanai</surname><given-names>A.</given-names></name><name><surname>Chiba</surname><given-names>H.</given-names></name><name><surname>Kuroki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>S.</given-names></name></person-group><year>2006</year>. <article-title>Monitoring markers of disease activity
for interstitial lung diseases with serum surfactant proteins A and D</article-title>.
<source><italic>Respirology</italic></source><volume>11</volume><issue>Suppl.</issue>:
<fpage>S51</fpage>&#x2013;<lpage>S54</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1440-1843.2006.00809.x</pub-id><pub-id pub-id-type="pmid">16423272</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Viitanen</surname><given-names>S. J.</given-names></name><name><surname>Laurila</surname><given-names>H. P.</given-names></name><name><surname>Lilja-Maula</surname><given-names>L. I.</given-names></name><name><surname>Melamies</surname><given-names>M. A.</given-names></name><name><surname>Rantala</surname><given-names>M.</given-names></name><name><surname>Rajamaki</surname><given-names>M. M.</given-names></name></person-group><year>2014</year>. <article-title>Serum C-reactive protein as a diagnostic
biomarker in dogs with bacterial respiratory diseases</article-title>.
<source><italic>J. Vet. Intern. Med.</italic></source><volume>28</volume>:
<fpage>84</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jvim.12262</pub-id><pub-id pub-id-type="pmid">24351049</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Walker</surname><given-names>S. R.</given-names></name><name><surname>Williams</surname><given-names>M. C.</given-names></name><name><surname>Benson</surname><given-names>B.</given-names></name></person-group><year>1986</year>. <article-title>Immunocytochemical localization of the
major surfactant apoproteins in type II cells, Clara cells, and alveolar macrophages of
rat lung</article-title>. <source><italic>J. Histochem.
Cytochem.</italic></source><volume>34</volume>: <fpage>1137</fpage>&#x2013;<lpage>1148</lpage>.
doi: <pub-id pub-id-type="doi">10.1177/34.9.2426341</pub-id><pub-id pub-id-type="pmid">2426341</pub-id></mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Yamaya</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Watari</surname><given-names>T.</given-names></name><name><surname>Asano</surname><given-names>R.</given-names></name></person-group><year>2014</year>. <article-title>Bronchoalveolar lavage fluid and serum
canine surfactant protein A concentrations in dogs with chronic cough by bronchial and
interstitial lung diseases</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><volume>76</volume>: <fpage>593</fpage>&#x2013;<lpage>596</lpage>. doi:
<pub-id pub-id-type="doi">10.1292/jvms.13-0428</pub-id><pub-id pub-id-type="pmid">24366151</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
